Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension

Susan P. Mollan; Clare L. Fraser; Kathleen B. Digre; Hans Christoph Diener; Richard B. Lipton; Marianne Juhler; Neil R. Miller; Patricia Pozo-Rosich; Mansoureh Togha; Kristian Brock; Marc J. Dinkin; Carmen K. M. Chan; Cristina Tassorelli; Alex J. Sinclair; Gisela M. Terwindt; Rigmor H. Jensen

doi:10.1177/03331024231197118

Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension

Susan P. Mollan^*, Clare L. Fraser, Kathleen B. Digre, Hans Christoph Diener, Richard B. Lipton, Marianne Juhler, Neil R. Miller, Patricia Pozo-Rosich, Mansoureh Togha, Kristian Brock, Marc J. Dinkin, Carmen K. M. Chan, Cristina Tassorelli, Alex J. Sinclair, Gisela M. Terwindt, Rigmor H. Jensen

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

18 Citations (Scopus)

65 Downloads (Pure)

Abstract

The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

Original language	English
Pages (from-to)	1-25
Number of pages	25
Journal	Cephalalgia
Volume	43
Issue number	8
DOIs	https://doi.org/10.1177/03331024231197118
Publication status	Published - Aug 2023
Externally published	Yes

Bibliographical note

Copyright the International Headache Society 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

drug
Guidelines
headache
Idiopathic intracranial hypertension
lumbar puncture
papilloedema
Pseudotumor cerebri
raised intracranial pressure
Randomised control trial
vision

Access to Document

10.1177/03331024231197118Licence: CC BY-NC

Publisher version (open access)Final published version, 925 KBLicence: CC BY-NC

Cite this

Mollan, S. P., Fraser, C. L., Digre, K. B., Diener, H. C., Lipton, R. B., Juhler, M., Miller, N. R., Pozo-Rosich, P., Togha, M., Brock, K., Dinkin, M. J., Chan, C. K. M., Tassorelli, C., Sinclair, A. J., Terwindt, G. M., & Jensen, R. H. (2023). Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension. Cephalalgia, 43(8), 1-25. https://doi.org/10.1177/03331024231197118

@article{252762a9512f4535927f91f10a756e2a,

title = "Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension",

abstract = "The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.",

keywords = "drug, Guidelines, headache, Idiopathic intracranial hypertension, lumbar puncture, papilloedema, Pseudotumor cerebri, raised intracranial pressure, Randomised control trial, vision",

author = "Mollan, \{Susan P.\} and Fraser, \{Clare L.\} and Digre, \{Kathleen B.\} and Diener, \{Hans Christoph\} and Lipton, \{Richard B.\} and Marianne Juhler and Miller, \{Neil R.\} and Patricia Pozo-Rosich and Mansoureh Togha and Kristian Brock and Dinkin, \{Marc J.\} and Chan, \{Carmen K. M.\} and Cristina Tassorelli and Sinclair, \{Alex J.\} and Terwindt, \{Gisela M.\} and Jensen, \{Rigmor H.\}",

note = "Copyright the International Headache Society 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2023",

month = aug,

doi = "10.1177/03331024231197118",

language = "English",

volume = "43",

pages = "1--25",

journal = "Cephalalgia",

issn = "0333-1024",

publisher = "SAGE Publications",

number = "8",

}

Mollan, SP, Fraser, CL, Digre, KB, Diener, HC, Lipton, RB, Juhler, M, Miller, NR, Pozo-Rosich, P, Togha, M, Brock, K, Dinkin, MJ, Chan, CKM, Tassorelli, C, Sinclair, AJ, Terwindt, GM & Jensen, RH 2023, 'Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension', Cephalalgia, vol. 43, no. 8, pp. 1-25. https://doi.org/10.1177/03331024231197118

TY - JOUR

T1 - Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension

AU - Mollan, Susan P.

AU - Fraser, Clare L.

AU - Digre, Kathleen B.

AU - Diener, Hans Christoph

AU - Lipton, Richard B.

AU - Juhler, Marianne

AU - Miller, Neil R.

AU - Pozo-Rosich, Patricia

AU - Togha, Mansoureh

AU - Brock, Kristian

AU - Dinkin, Marc J.

AU - Chan, Carmen K. M.

AU - Tassorelli, Cristina

AU - Sinclair, Alex J.

AU - Terwindt, Gisela M.

AU - Jensen, Rigmor H.

N1 - Copyright the International Headache Society 2023. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2023/8

Y1 - 2023/8

N2 - The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

AB - The quality of clinical trials is essential to advance treatment, inform regulatory decisions and meta-analysis. With the increased incidence of idiopathic intracranial hypertension and the emergence of clinical trials for novel therapies in this condition, the International Headache Society Guidelines for Controlled Clinical Trials in Idiopathic Intracranial Hypertension aims to establish guidelines for designing state-of-the-art controlled clinical trials for idiopathic intracranial hypertension.

KW - drug

KW - Guidelines

KW - headache

KW - Idiopathic intracranial hypertension

KW - lumbar puncture

KW - papilloedema

KW - Pseudotumor cerebri

KW - raised intracranial pressure

KW - Randomised control trial

KW - vision

UR - https://www.scopus.com/pages/publications/85169650354

U2 - 10.1177/03331024231197118

DO - 10.1177/03331024231197118

M3 - Article

C2 - 37661711

AN - SCOPUS:85169650354

SN - 0333-1024

VL - 43

SP - 1

EP - 25

JO - Cephalalgia

JF - Cephalalgia

IS - 8

ER -

Guidelines of the International Headache Society for Controlled Clinical Trials in idiopathic intracranial hypertension

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this